In our previous study on GluN2A expression in AD brain tissue, GluN2A levels were significantly reduced in Braak stages III–IV and exhibited a decreasing trend in the earlier Braak stages (Escamilla, Badillos, et al. 2024 ).
← all excerpts
Alterations of NMDAR Subunits in the Cerebrospinal Fluid Across Neurodegenerative and Immunological Disorders.
1
—
—